Previous Section Index Home Page

21 Feb 2005 : Column 128W—continued

Warships

Mr. Soames: To ask the Secretary of State for Defencewhat he expects the average age by 2009 of the Royal Navy's (a) frigate fleet and (b) destroyer fleet tobe. [216107]

Mr. Ingram: By 2009 the average age of a Royal Navy frigate will be around 15 years and of a destroyer around 25 years.
 
21 Feb 2005 : Column 129W
 

Mr. Soames: To ask the Secretary of State for Defencehow many new (a) frigates and (b) destroyers will be delivered to the Royal Navy between 2005 and 2009. [216110]

Mr. Ingram: The first of class type 45 destroyer, HMS Daring, is planned to enter service in 2009. There are no plans to deliver any new Royal Navy frigates or destroyers before then.

HEALTH

Abortion

Jim Dobbin: To ask the Secretary of State for Health what plans he has to extend section 1(3a) of the Abortion Act 1967 to allow women to have abortions at home. [215176]

Miss Melanie Johnson: All abortions in England are currently carried out in a national health service hospital or an approved independent sector place. There are no current plans to change this.

Accident and Emergency Services

Mr. Flight: To ask the Secretary of State for Health what assessment he has made of the impact of the introduction of (a) the new general practitioner contract and (b) the four-hour waiting time target for accident and emergency attendances on the demand for accident and emergency services. [215137]

Ms Rosie Winterton: The available evidence shows no relationship between the new general practitioner contract and demand for accident and emergency (Aand E) services. Rising demand for emergency care is a trend that long predates this change or the four hour A and E target.

Factors involved in recent reported rises in demand include the better range of services now available, together with the improved reporting and increased patient satisfaction that the progress in cutting A and E waits has delivered.
 
21 Feb 2005 : Column 130W
 

Mr. Michael Foster: To ask the Secretary of State for Health how many patients have been treated in accident and emergency departments in hospitals in Worcestershire in each year since 1997; and if he will make a statement. [215001]

Dr. Ladyman: Data were not collected centrally on an individual trust basis prior to 2000–01. The table shows the number of first attendances, follow up attendances and total attendances for the Worcestershire Acute Hospitals National Health Service Trust from 2000–01 up to and including the second quarter of 2004–05.
First attendancesFollow up attendancesTotal attendances
2000–01(38)115,6446,702122,346
2001–02(38)114,9667,302122,268
2002–03(39)116,3667,556123,922
2003–04(39)120,4077,406127,813
2004–05 quarters 1 and 2(39)66,8922,00668,898




Note:
The figures include attendances at major accident and emergency departments and minor injuries units. The figures include all type1 (major A and E), 2 or 3 (which include minor injuries units and walk-in-centres) A and E services that a trust provides.
Sources:
(38)Department of Health form KH09.
(39)Department of Health dataset QMAE.


Mr. Chidgey: To ask the Secretary of State for Healthwhat plans he has to relocate the accident and emergency department at the Royal County Hospital, Winchester. [214573]

Ms Rosie Winterton [holding answer 9 February 2005]: In line with our policy of Shifting the Balance of Power, decisions about the configuration of local health services are made locally by primary care trusts in partnership with strategic health authorities and other local stakeholders. This process provides the means for addressing local needs within the health community, including the provision of accident and emergency services.

Mr. Flook: To ask the Secretary of State for Health how many people in (a) Taunton and (b) Somerset used accident and emergency services in each of the last five years. [214475]

Ms Rosie Winterton: The information requested is shown in the table.
Attendances at accident and emergency departments, minor injury units and walk in centres, national health service organisations in England, 2000–01 to quarter 2 (Q2) 2004–05

Up to Q2 2004–052003–042002–032001–022000–01
RA4East Somerset NHS Trust19,94139,88439,78439,37937,813
5FXMendip PCT13,78023,0464,69019,449
5FWSomerset Coast PCT15,32428,801
5K1South Somerset PCT1,0921,834867
RBATaunton and Somerset NHS Trust24,15544,99474,94676,02473,632
5FLBath and North East Somerset PCT16,28928,38314,47313,850
5M8North Somerset PCT4,6819,374
Total99,578183,292145,189158,437111,445




Source:
Department of Health dataset QMAE/KH09.



Alcohol Misuse

Sandra Gidley: To ask the Secretary of State for Health what assessment he has made of the incidence of alcohol-related problems in the under 60s. [214933]

Miss Melanie Johnson: The alcohol harm reduction strategy for England takes a cross Government approach to reducing harm caused by alcohol. Data is listed from hospital episode statistics where the primary diagnosis or cause code shows incidence of alcohol-
 
21 Feb 2005 : Column 131W
 
related problems available specifically for the age range 'under 60s'.
Counts of finished in-year admissions where there was a primary diagnosis code or cause code for selected alcohol related diseases. Age at admission up to 60 years—national health service hospitals, England 2003–04

Primary diagnosisAdmissions
F10.0—Acute intoxication8,937
F10.1—Harmful use2,012
F10.2—Dependence syndrome8,946
F10.3—Withdrawal state6,023
F10.4—Withdrawal state with delirium858
F10.5—Psychotic disorder370
F10.6—Amnesic syndrome142
F10.7—Residual and late-onset psychotic disorder52
F10.8—Other mental and behavioural disorders52
F10.9—Unspecified mental and behavioural disorders506
K70—Alcoholic liver disease9,543
T51—Toxic effect of alcohol1,424
Cause code
X45—Accidental poisoning by and exposure to alcohol




Notes:
1.Finished in-year admissions—A finished in-year admission is the first period of in-patient care under one consultant within one healthcare provider, excluding admissions beginning before 1 April at the start of the datayear. Please note that admissions do not represent the number of in-patients, as a person may have more than one admission within the year.
2.Diagnosis (primary diagnosis)—The primary diagnosis is the first of up to 14 (seven prior to 2002–03) diagnosis fields in the Hospital Episode Statistics (HES) data set and provides the main reason why the patient was in hospital.
3.Cause code—The cause code is a supplementary code that indicates the nature of any external cause of injury, poisoning or other adverse effects.
4.Ungrossed data—Figures have not been adjusted for shortfalls in data (i.e. the data are ungrossed).
Source:
Hospital Episode Statistics (HES), Department of Health



Alzheimer's Disease

Dr. Gibson: To ask the Secretary of State for Health (1) if he will make a statement on the availability, in advance of the outcome of the appraisal by the National Institute for Clinical Excellence, of Ebixa on the NHS for advanced Alzheimer's disease; [214529]

(2) what guidance he has issued to (a) primary care trusts and (b) other funding organisations regarding the availability, in advance of the outcome of the appraisal by the National Institute for Clinical Excellence, of Ebixa on the NHS for advanced Alzheimer's disease; and if he will make a statement; [214530]

(3) what representations he has received regarding the availability of Ebixa for advanced Alzheimer's disease; and if he will make a statement. [214531]

Ms Rosie Winterton: National Institute for Clinical Excellence (NICE) Appraisal Guidance No. 19, relating to the use of Donepezil, Rivastigmine, and Galantamine for the treatment of patients with mild to moderate
 
21 Feb 2005 : Column 132W
 
Alzheimer's disease, was issued in January 2001. This guidance is currently under review, and the revised version due for publication in July 2005 will include an assessment of Memantine Hydrochloride (Ebixa).

I have received a number of representations on the availability of Ebixa since the product received its license.

In August 1999, the Department issued Health Service Circular 1999/176, which asks national health service bodies to continue with local arrangements for the managed introduction of new technologies where guidance from NICE is not published at the time the technology first becomes available in the United Kingdom. These arrangements should involve an assessment of the available evidence.


Next Section Index Home Page